BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Events

Akeso Showcases Positive Phase III Safety Run-In Data for Cadonilimab at SGO 2025 in Locally Advanced Cervical Cancer

Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society ...

March 24, 2025 | Report

VantAI Introduces Neo-1, the First Unified Model for De Novo Molecular Generation and Structure Prediction

Neo-1 is the first model to unify de novo molecular generation and atomic-level structure prediction in a single model, by generating latent representa...

March 24, 2025 | News

Dizal to Present New Findings on Golidocitinib-PD-1 Combo and Sunvozertinib-Anlotinib Therapy at ELCC 2025

Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced ...

March 21, 2025 | News

TPIsoftware & Yuan's General Hospital Transform Healthcare with GenAI Platform

TPIsoftware (TWSE: 7781) and Yuan's General Hospital, a leading medical institution in Southern Taiwan, have collaborated to launch a digit...

March 20, 2025 | News

Navigating Biologics Development: Strategies for Regulatory Success, CMC Challenges, and Tech Transfer

Click here to Register Now! As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for...

March 12, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU Recommended for EU Approval for HER2 Low and HER2 Ultralow Metastatic Breast Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been recommended for approval in th...

March 03, 2025 | News

Webinar from ProBio: Multiple Solutions of Antibody Discovery and Engineering

Click here to Register Now! Topic 1: Solution of functional lead discovery via integrated antibody generation platform The screening funnel of therapeu...

February 20, 2025 | News

Hong Kong Genome Institute Partners with Global Leaders to Advance Genomic Medicine at International Symposium

HKGI Partners with Global Leaders to Chart a Course for Healthcare Transformation HONG KONG, Feb. 19, 2025 /PRNewswire/ -- Genomic medicine...

February 20, 2025 | News

CanSinoBIO Showcases Vaccine Innovation and Global Health Commitment at 2025 World Government Summit

CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in Dubai...

February 18, 2025 | News

Mental Health Tops Health Concerns in Singapore, Surpassing Cancer and COVID-19

High demand: Mental health now tops health concerns in Singapore, surpassing cancer and COVID-19. New regional hub: MHIN Asia Hub, based in Si...

February 18, 2025 | News

RemeGen Presents Promising Phase II Trial Results for Disitamab Vedotin and Toripalimab in Muscle-Invasive Bladder Cancer at ASCO GU 2025

RemeGen Co., Ltd. (RemeGen) has announced new efficacy and safety data from the Phase II clinical trial (NCT05297552, Study ID: RC48-C017) evaluating Disit...

February 17, 2025 | News

Innovent’s IBI363 Secures Second FDA Fast Track Designation for Advanced Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

February 17, 2025 | News

CMU and Healthcare System Showcase AI-Driven Breakthroughs in Cancer Therapy and Drug Discovery at Healthcare Expo Taiwan

China Medical University (CMU) and Healthcare System showcased groundbreaking advancements in AI-driven drug discovery and cancer therapy at the 8t...

February 06, 2025 | Report

GC Cell Hosts Landmark Symposium in Indonesia to Spotlight Immuncell-LC Cancer Immunotherapy

GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia....

January 24, 2025 | News

Stay Connected